A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

James C. Barrow

doi:10.1021/acsmedchemlett.9b00107

A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

James C. Barrow

School of Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.

Original language	English (US)
Pages (from-to)	687-689
Number of pages	3
Journal	ACS Medicinal Chemistry Letters
Volume	10
Issue number	5
DOIs	https://doi.org/10.1021/acsmedchemlett.9b00107
State	Published - May 9 2019

Keywords

Medicinal chemistry
academic drug discovery
innovation
translational science

ASJC Scopus subject areas

Biochemistry
Drug Discovery
Organic Chemistry

Access to Document

10.1021/acsmedchemlett.9b00107

Cite this

@article{8c5ab0d584bf4881a24b69eb5ee595e9,

title = "A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery",

abstract = "Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.",

keywords = "Medicinal chemistry, academic drug discovery, innovation, translational science",

author = "Barrow, {James C.}",

note = "Publisher Copyright: {\textcopyright} 2019 American Chemical Society.",

year = "2019",

month = may,

day = "9",

doi = "10.1021/acsmedchemlett.9b00107",

language = "English (US)",

volume = "10",

pages = "687--689",

journal = "ACS Medicinal Chemistry Letters",

issn = "1948-5875",

publisher = "American Chemical Society",

number = "5",

}

TY - JOUR

T1 - A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

AU - Barrow, James C.

PY - 2019/5/9

Y1 - 2019/5/9

N2 - Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.

AB - Medicinal chemists have increasing opportunities to transition from the pharmaceutical industry to academic medical centers interested in translational research. This Viewpoint highlights some of the differences between these two cultures and strategies to succeed in academic drug discovery.

KW - Medicinal chemistry

KW - academic drug discovery

KW - innovation

KW - translational science

UR - http://www.scopus.com/inward/record.url?scp=85065055532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065055532&partnerID=8YFLogxK

U2 - 10.1021/acsmedchemlett.9b00107

DO - 10.1021/acsmedchemlett.9b00107

M3 - Review article

C2 - 31097980

AN - SCOPUS:85065055532

SN - 1948-5875

VL - 10

SP - 687

EP - 689

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

IS - 5

ER -

A Medicinal Chemist's Perspective on Transitioning from Industry to Academic Drug Discovery

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this